Presentation: CTTI’s Comprehensive Guide to Mobile Technologies in Clinical Trials Date: Thurs., Oct. 11 Presenters: Abby Bronson (Parent Project Muscular Dystrophy), Ray Dorsey (University of Rochester), and Linda Ricci (FDA/CDRH)
Presentation: Advancing the Use of Mobile Technologies for Data Capture & Improved Clinical Trials: Recommendations from the Clinical Trials Transformation Initiative Presenter: Jennifer Goldsack (CTTI)
On March 31, the U.S. Department of Health and Human Services (HHS) will unveil the latest edition of Healthy People! The event is at the George Washington University, and you can attend in person or via webcast. Register for the event now. Register here.
Dyan Bryson, Adam Federman, and Sheila Mahoney Jewels invite you to participate in this monthly meeting as we raise awareness of and take action on D&I in life sciences - both from the perspective of diversity in clinical trials and corprorate recruitment and promotion. Each month we offer speakers and discussion on how to take […]
For October only, thanks to our sponsor Allscripts, we’re inviting all STAT readers to join our STAT+ Conversations.
Each week, tune in to hear from STAT reporters and leaders in health and medicine as they discuss the industry's most pressing issues, and take your questions live.
Register here to join next week's discussion hosted by STAT national technology correspondent Casey Ross and featuring executives from Takeda and the Bill & Melinda Gates Foundation.
OCTOBER 20 Beyond real-world data and Covid-19
Anne Heatherington, Ph.D., senior vice president and head of Data Sciences Institute, Takeda
Steven Kern, Ph.D., deputy director, quantitative sciences, Bill & Melinda Gates Foundation
Casey Ross, national technology correspondent, STAT (moderator)
Sponsor Introduction by Rebecca Whaley, vice president of marketing, AllScripts
The coronavirus outbreak has exacerbated the complicated lives of many patients. The need to step up the emergency response to the global pandemic has put at risk advancements in patient-focused medicines development and, by necessity, deprioritized various patient engagement efforts. How has the pandemic affected the lives of patients and their access to care, both […]
Biotech and pharma teams are working to get the intelligence needed to deliver new treatments and improve patient outcomes. Those with rare diseases and sub-indications are difficult to identify so some brands are getting creative with real-world data and analytics strategies to better understand true market need. In this Conversations in Healthcare Panel, DRG's Mike […]